Stock Based Compensation (Tables)

6 Months Ended

Jun. 30, 2022

Stock Based Compensation

Summary of incentive plan activity

				Weighted		Weighted Average
	Shares	Stock		Average		Remaining	Aggregate
	Available	Options	RSUs	Stock Option		Contractual Life	Intrinsic
(in thousands, except share and per share data)	for Grant	Outstanding	Outstanding	Exercise Price		(Years)	Value*
Outstanding at December 31, 2021	631,270	2,503,075	487,456	$	9.44	8.35	$	3
Additional shares authorized	2,889,493	—	—		—			—
Options granted	(3,333)	3,333	—		0.31			—
Options exercised	—	—	—		—			—
Options canceled	69,174	(69,174)	—		3.89			—
RSUs granted	(2,888,630)	—	2,888,630		—			—
Outstanding at June 30, 2022	697,974	2,437,234	3,376,086	$	9.58	7.86	$	—
Exercisable at June 30, 2022		1,827,974		$	11.10	7.58	$	—
Vested and expected to vest at June 30, 2022		2,361,501		$	9.72	7.83	$	—

*Fair market value of JAGX common stock on June 30, 2022 was $0.30 per share.

Summary of stock-based compensation expense

	Three Months Ended				Six Months Ended
	June 30,				June 30,
(in thousands)	2022		2021		2022		2021
	(unaudited)				(unaudited)
Research and development expense	$	365	$	366	$	713	$	531
Sales and marketing expense		120		68		202		121
General and administrative expense		532		597		1,165		1,015
Total	$	1,017	$	1,031	$	2,080	$	1,667

Employee stock options

Stock Based Compensation

Schedule of estimated grant-date fair value of stock options calculated using the Black-Scholes option-pricing model

	Six Months Ended
	June 30,
	2022	2021
	(unaudited)
Volatility	164.0%	163.8 - 164.0 %
Expected term (years)	5.0	5.0
Risk-free interest rate	3.2%	0.5 - 1.0 %
Expected dividend yield	—	—